Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
Clinical trial NCT06629818 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06629818
- Sponsor
- Peking Union Medical College Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2026-10-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.